Definium Therapeutics (DFTX) EPS (Basic) (2021 - 2026)
Definium Therapeutics (DFTX) posted quarterly EPS (Basic) of -$0.71 for Q1 2026, down 158.21% year-over-year from $1.22 in Q1 2025, and down 25.51% quarter-over-quarter from -$0.56 in Q4 2025.
Powered by 
Analysis
Definium Therapeutics (DFTX) EPS (Basic) (2021 - 2026) Analysis & Trends
Definium Therapeutics (DFTX) has reported EPS (Basic) for 6 consecutive years, with -$0.71 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) fell 158.21% year-over-year to -$0.71; the TTM figure through Mar 2026 stood at -$2.18 (down 139.28% YoY), while the FY2025 annual figure was -$2.06, down 33.4% from the prior year.
- EPS (Basic) slipped to -$0.71 in Q1 2026 per DFTX's latest filing, from -$0.56 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.08 in Q2 2024 and bottomed at -$1.14 in Q1 2024.
- Historically, EPS (Basic) has averaged -$0.55 across 5 years, with a median of -$0.55 in 2023.
- Annual changes were most pronounced in 2024 — EPS (Basic) jumped 88.73% — and 2025, when it plunged 515.23%.
- Definium Therapeutics' EPS (Basic) stood at -$0.17 in 2022, then sank by 233.24% to -$0.55 in 2023, then gained by 10.95% to -$0.49 in 2024, then retreated by 14.51% to -$0.56 in 2025, then dropped by 25.51% to -$0.71 in 2026.
- Business Quant data shows DFTX's EPS (Basic) at -$0.71 in Q1 2026, -$0.56 in Q4 2025, and -$0.78 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Definium Therapeutics | 4.23 Bn | 4.23 Bn | - | -1.44 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.44 |
| Mar 31, 2026 | -0.71 |
| Dec 31, 2025 | -0.56 |
| Sep 30, 2025 | -0.78 |
| Jun 30, 2025 | -0.50 |
| Mar 31, 2025 | -0.27 |
| Dec 31, 2024 | -0.49 |
| Sep 30, 2024 | -0.18 |
| Jun 30, 2024 | -0.08 |
| Mar 31, 2024 | -1.14 |
| Dec 31, 2023 | -0.54 |
| Sep 30, 2023 | -0.51 |
| Jun 30, 2023 | -0.72 |
| Mar 31, 2023 | -0.51 |
| Dec 31, 2022 | 0.07 |
| Sep 30, 2022 | -0.56 |
| Jun 30, 2022 | -0.60 |
| Mar 31, 2022 | -0.66 |
| Dec 31, 2021 | 0.07 |
| Sep 30, 2021 | -0.61 |